4//SEC Filing
Trachtenberg Eric 4
Accession 0001415889-22-000401
CIK 0001479419other
Filed
Jan 4, 7:00 PM ET
Accepted
Jan 5, 8:00 PM ET
Size
7.8 KB
Accession
0001415889-22-000401
Insider Transaction Report
Form 4
Trachtenberg Eric
General Counsel and Secretary
Transactions
- Award
Stock Option (right to buy)
2022-01-03+153,000→ 153,000 totalExercise: $1.37Exp: 2032-01-03→ Common Stock (153,000 underlying) - Sale
Common Stock
2022-01-04$1.30/sh−2,850$3,705→ 113,816 total
Footnotes (4)
- [F1]This sale was made pursuant to a 10b5-1 trading plan to cover tax withholding obligations in connection with the vesting and settlement of the Reporting Person's restricted stock units granted on January 4, 2021.
- [F2]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.25 to $1.39, inclusive. The Reporting Person undertakes to provide to Kala Pharmaceuticals, Inc., any security holder of Kala Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.
- [F3]Includes 53,611 unvested RSUs.
- [F4]This option was granted on January 3, 2022 and vests with respect to 1/48th of the shares underlying the option at the end of each successive one-month period thereafter.
Documents
Issuer
Kala Pharmaceuticals, Inc.
CIK 0001479419
Entity typeother
Related Parties
1- filerCIK 0001646300
Filing Metadata
- Form type
- 4
- Filed
- Jan 4, 7:00 PM ET
- Accepted
- Jan 5, 8:00 PM ET
- Size
- 7.8 KB